COMMUNIQUÉS West-GlobeNewswire

Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura
19/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference
19/10/2018
AEB4104 is a Novel Engineered Human Enzyme with Unique Specificity for Degrading Both Homocysteine and Homocystine AEB4104 Prevents Death, Stops Disease Progression, and Reverses Liver Pathology in a Disease Model of [...]
Palvella Therapeutics to Present Update on PTX-022 at Pachyonychia Congenita Project Patient Support Meeting in London, UK
19/10/2018
Wayne, PA, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. , a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for debilitating genetic [...]
Sanofi receives positive CHMP opinion for dengue vaccine
19/10/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi receives positive CHMP opinion for dengue vaccine Paris, France - October 19, 2018 - The European Medicines Agency's Committee for Medicinal Products for [...]
Sanofi obtient un avis positif du CHMP pour son vaccin contre la dengue
19/10/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi obtient un avis positif du CHMP pour son vaccin contre la dengue Paris, France - Le 19 octobre 2018 - Le Comité des médicaments à usage humain ( [...]
Integrated Cannabis Company, Inc. to Acquire Assets of Colorado-Based Cannabis Innovator, Critical Mass Industries, LLC, With an Estimated USD $7 Million in Annual Revenue
19/10/2018
VANCOUVER, British Columbia, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”), is pleased to announce the signing of a Letter of Intent (the “ LOI [...]
BioCorRx Strengthens Intellectual Property Portfolio with Acquisition of Several Patent/Patent Pending Families
19/10/2018
Issued patents, in addition to other intellectual property (IP) rights, cover hydrophobic drug-delivery material for BICX101 Divisional patent applications filed to strengthen BioCorRx’s intellectual property position [...]
MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada
19/10/2018
Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond Previously Announced Spine and Neuro License Agreement IRVINE, Calif., [...]
New Studies Highlight Performance of Vectra® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
19/10/2018
Data Show Vectra Test Is Correlated with Treatment Response SALT LAKE CITY, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced new data from [...]
Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX®2-73 in Patients with Rett Syndrome
19/10/2018
Study will incorporate genomic precision medicine ANAVEX®2-73-specific biomarkers NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
BeyondSpring to Host Second-Quarter 2018 Financial Results and Operational Update Conference Call on October 23, 2018
19/10/2018
Dr. Douglas Blayney from Stanford University to Join to Discuss Recently Announced Clinical Data NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc . (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical [...]
Orion Corporation: Managers' transactions - Sydäntutkimussäätiö sr.
19/10/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 19 October 2018 at 13.45 EEST Orion Corporation: Managers' transactions - Sydäntutkimussäätiö sr. Orion Corporation has received the following disclosure under Market Abuse [...]
Digirad Corporation to Release 2018 Third Quarter Financial Results on November 2, 2018
19/10/2018
Conference Call and Webcast Set for 11:00 a.m. EDT SUWANEE, Ga., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) will release financial results for its third quarter ended September 30, 2018 before [...]
PCI Biotech to present Phase I dose escalation results at ESMO
19/10/2018
Oslo, Norway, 19 October 2018 — PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company will present results from the Phase I dose escalation study in perihilar [...]
Immunicum AB (publ) Announces Nomination Committee for AGM 2019
19/10/2018
Press Release 19 October 2018 Immunicum AB (publ) Announces Nomination Committee for AGM 2019 Immunicum AB (publ) in accordance with the principles of appointing the Nomination Committee, adopted by the Annual General [...]
Rule 2.9 Announcement
19/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 October 2018 [...]
Oxurion NV Business Update - Q3 2018
19/10/2018
Shareholders' Approval and Launch of Oxurion NV as new Company Name First patient enrolled in Phase 1 study evaluating THR-687, a Novel Pan-RGD Integrin Antagonist, for Treatment of Diabetic Macular Edema (DME) First [...]
Novartis announces presentation of new Lutathera® NETTER-1 data at ESMO demonstrating significant improvement in PFS regardless of baseline liver tumor burden
19/10/2018
Lutathera treatment was associated with an ~80% reduction in the estimated risk of tumor progression or death vs comparator, regardless of baseline liver tumor burden[1] Lutathera treatment was associated with a [...]
Kiadis Pharma raises €31.2 million in a private placement of 3.9 million new shares
19/10/2018
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]

Pages